Breaking News

Ablexis Licenses ADC Voyager Technology

Will use AlivaMab Mouse for antibody drug discovery and development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, has entered a license agreement with Voyager Therapeutics, gaining non-exclusive license to use the AlivaMab Mouse for antibody drug discovery and development. Financial terms include an undisclosed upfront payment, development milestones and a royalty on product sales.   “Ablexis welcomes Voyager Therapeutics to the growing list of leading biopharmaceutical companies using...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters